Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Amato, Felice ^a,b   Tomaiuolo, Rossella ^a,b   Nici, Fabrizia ^c   Borbone, Nicola ^c   Elce, Ausilia ^a,b,d   Catalanotti, Bruno ^c   D'Errico, Stefano ^c   Morgillo, Carmine Marco ^c   De Rosa, Giuseppe ^c   Mayol, Laura ^c   Piccialli, Gennaro ^c   Oliviero, Giorgia ^c   Castaldo, Giuseppe ^a,b  

^a Dipartimento di Biochimica e Biotecnologie Mediche   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITÀ TELEMATICA PEGASO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODUPLEX; LUCIFERASE; MICRORNA; MICRORNA 509 3P; NUCLEASE; PEPTIDE NUCLEIC ACID; RNA; UNCLASSIFIED DRUG; FLUORESCEIN ISOTHIOCYANATE; MIRN509 MICRORNA, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL LINE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR DYNAMICS; PROTEIN STRUCTURE; RNA STABILITY; TRANSCRIPTION REGULATION; ANTAGONISTS AND INHIBITORS; CIRCULAR DICHROISM; DNA DENATURATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RADIATION RESPONSE; SYNTHESIS; TUMOR CELL LINE; ULTRAVIOLET RADIATION; ULTRAVIOLET SPECTROPHOTOMETRY;

CELL LINE, TUMOR; CIRCULAR DICHROISM; CYSTIC FIBROSIS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCEIN-5-ISOTHIOCYANATE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID DENATURATION; PEPTIDE NUCLEIC ACIDS; SPECTROPHOTOMETRY, ULTRAVIOLET; ULTRAVIOLET RAYS;

EID: 84900009626     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/610718     Document Type: Article

References (50)

1. He L., Hannon G. J., MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 2004 5 7 522 531 2-s2.0-3042767202 10.1038/nrg1379
2. Griffiths-Jones S., Saini H. K., van Dongen S., Enright A. J., miRBase: tools for microRNA genomics. Nucleic Acids Research 2008 36 1 D154 D158 2-s2.0-38549150275 10.1093/nar/gkm952
3. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N., Widespread changes in protein synthesis induced by microRNAs. Nature 2008 455 7209 58 63 2-s2.0-49949117302 10.1038/nature07228
4. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.-C., Gram H., Han J., Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005 120 5 623 634 2-s2.0-20044388720 10.1016/j.cell.2004.12.038
5. Brennecke J., Stark A., Russell R.B., Cohen S. M., Silencing of microRNA families by seed-targeting tiny LNAs. Nature Genetics 2011 43 371 378
6. Castaldo G., Lembo F., Tomaiuolo R., Molecular diagnostics: between chips and customized medicine. Clinical Chemistry and Laboratory Medicine 2010 48 7 973 982 2-s2.0-77954228225 10.1515/CCLM.2010.182
7. Bader A. G., Brown D., Winkler M., The promise of microRNA replacement therapy. Cancer Research 2010 70 18 7027 7030 2-s2.0-77956901498 10.1158/0008-5472.CAN-10-2010
8. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., Croce C. M., Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E -miR155 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 18 7024 7029 2-s2.0-33646471662 10.1073/pnas.0602266103
9. Rodriguez A., Vigorito E., Clare S., Warren M. V., Couttet P., Soond D. R., Van Dongen S., Grocock R. J., Das P. P., Miska E. A., Vetrie D., Okkenhaug K., Enright A. J., Dougan G., Turner M., Bradley A., Requirement of bic/microRNA-155 for normal immune function. Science 2007 316 5824 608 611 2-s2.0-34247584465 10.1126/science.1139253
10. Brown P. N., Yin H., PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells. Chemical Communications 2013 49 4415 4417
11. Ullah S., John P., Bhatti A., MicroRNAs with a role in gene regulation and in human diseases. Molecular Biology Reports 2013 10.1007/s11033-013-2855-1
12. Li Y., Kowdley K. V., MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics 2012 10 246 253
13. McIntosh I., Cutting G. R., Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis. FASEB Journal 1992 6 10 2775 2782 2-s2.0-0026732670
14. Gillen A. E., Gosalia N., Leir S.-H., Harris A., microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochemical Journal 2011 438 1 25 32 2-s2.0-79960807167 10.1042/BJ20110672
15. Amato F., Seia M., Giordano S., Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis? PLoS ONE 2013 8 e60448
16. van Rooij E., Purcell A. L., Levin A. A., Developing MicroRNA therapeutics. Circulation Research 2012 110 3 496 507 2-s2.0-84856751210 10.1161/CIRCRESAHA.111.247916
17. van Rooij E., Olson E. N., MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature Reviews Drug Discovery 2012 11 860 872
18. Rayner K. J., Esau C. C., Hussain F. N., McDaniel A. L., Marshall S. M., Van Gils J. M., Ray T. D., Sheedy F. J., Goedeke L., Liu X., Khatsenko O. G., Kaimal V., Lees C. J., Fernandez-Hernando C., Fisher E. A., Temel R. E., Moore K. J., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011 478 7369 404 407 2-s2.0-80054971110 10.1038/nature10486
19. Esau C., Davis S., Murray S. F., Yu X. X., Pandey S. K., Pear M., Watts L., Booten S. L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B. A., Freier S., Bennett C. F., Bhanot S., Monia B. P., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006 3 2 87 98 2-s2.0-33645075443 10.1016/j.cmet.2006.01.005
20. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H. F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E. M., Kauppinen S., LNA-mediated microRNA silencing in non-human primates. Nature 2008 452 7189 896 899 2-s2.0-42249093319 10.1038/nature06783
21. Lanford R. E., Hildebrandt-Eriksen E. S., Petri A., Persson R., Lindow M., Munk M. E., Kauppinen S., Rum H., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010 327 5962 198 201 2-s2.0-74249112787 10.1126/science.1178178
22. Brognara E., Fabbri E., Aimi F., Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells. International Journal of Oncology 2012 41 2119 2127
23. Torres A. G., Fabani M. M., Vigorito E., Williams D., Al-Obaidi N., Wojciechowski F., Hudson R. H. E., Seitz O., Gait M. J., Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs. Nucleic Acids Research 2012 40 5 2152 2167 2-s2.0-84858405753 10.1093/nar/gkr885
24. Fabani M. M., Abreu-Goodger C., Williams D., Lyons P. A., Torres A. G., Smith K. G. C., Enright A. J., Gait M. J., Vigorito E., Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Research 2010 38 13 4466 4475 2-s2.0-77955263389 10.1093/nar/gkq160
25. Nielsen P. E., Egholm M., Berg R. H., Buchardt O., Sequence-selective recognition of DNA by strand displacement with thymine-substituted polyamide. Science 1991 254 5037 1497 1500 2-s2.0-0026341239
26. Pooga M., Land T., Bartfai T., Langel Ü., PNA oligomers as tools for specific modulation of gene expression. Biomolecular Engineering 2001 17 6 183 192 2-s2.0-0035012924 10.1016/S1389-0344(01)00075-2
27. Zhang X., Ishihara T., Corey D. R., Strand invasion by mixed base PNAs and a PNA-peptide chimera. Nucleic Acids Research 2000 28 17 3332 3338 2-s2.0-0034283848
28. Kushon S. A., Jordan J. P., Seifert J. L., Nielsen H., Nielsen P. E., Armitage B. A., Effect of secondary structure on the thermodynamics and kinetics of PNA hybridization to DNA hairpins. Journal of the American Chemical Society 2001 123 44 10805 10813 2-s2.0-0035823868 10.1021/ja016310e
29. Besch R., Giovannangeli C., Schuh T., Kammerbauer C., Degitz K., Characterization and quantification of triple helix formation in chromosomal DNA. Journal of Molecular Biology 2004 341 4 979 989 2-s2.0-3843129658 10.1016/j.jmb.2004.05.079
30. Nielsen P. E., Peptide Nucleic Acids (PNA) in chemical biology and drug discovery. Chemistry and Biodiversity 2010 7 4 786 804 2-s2.0-77951198765 10.1002/cbdv.201000005
31. Amato J., Stellato M. I., Pizzo E., PNA as a potential modulator of COL7A1 gene expression in dominant dystrophic epidermolysis bullosa: a physico-chemical study. Molecular BioSystems 2013 10.1039/c3mb70283a
32. Amato J., Oliviero G., de Pauw E., Gabelica V., Hybridization of short complementary PNAs to G-quadruplex forming oligonucleotides: an electrospray mass spectrometry study. Biopolymers 2009 91 4 244 255 2-s2.0-65249090347 10.1002/bip.21124
33. Amato J., Pagano B., Borbone N., Oliviero G., Gabelica V., Pauw E. D., Derrico S., Piccialli V., Varra M., Giancola C., Piccialli G., Mayol L., Targeting G-Quadruplex structure in the human c-Kit promoter with short PNA sequences. Bioconjugate Chemistry 2011 22 4 654 663 2-s2.0-79955034767 10.1021/bc100444v
34. Gaglione M., Milano G., Chambery A., Moggio L., Romanelli A., Messere A., PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents. Molecular BioSystems 2011 7 8 2490 2499 2-s2.0-79960378804 10.1039/c1mb05131h
35. Manicardi A., Fabbri E., Tedeschi T., Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells. ChemBioChem 2012 13 1327 1337
36. Egholm M., Buchardt O., Christensen L., Behrens C., Freier S. M., Driver D. A., Berg R. H., Kim S. K., Norden B., Nielsen P. E., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 1993 365 6446 566 568 2-s2.0-0027364174 10.1038/365566a0
37. Amato F., Tomaiuolo R., Borbone N., Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression. MedChemComm 2013 10.1039/c3md00257h
38. Obad S., dos Santos C. O., Petri A., Heidenblad M., Broom O., Ruse C., Fu C., Lindow M., Stenvang J., Straarup E. M., Hansen H. F., Koch T., Pappin D., Hannon G. J., Kauppinen S., Silencing of microRNA families by seed-targeting tiny LNAs. Nature Genetics 2011 43 4 371 380 2-s2.0-79953202455 10.1038/ng.786
39. Patrick D. M., Montgomery R. L., Qi X., Obad S., Kauppinen S., Hill J. A., Van Rooij E., Olson E. N., Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. Journal of Clinical Investigation 2010 120 11 3912 3916 2-s2.0-78049432896 10.1172/JCI43604
40. Lavery R., Moakher M., Maddocks J. H., Petkeviciute D., Zakrzewska K., Conformational analysis of nucleic acids revisited: curves+. Nucleic Acids Research 2009 37 17 5917 5929 2-s2.0-70450261721 10.1093/nar/gkp608 gkp608
41. Humphrey W., Dalke A., Schulten K., VMD: visual molecular dynamics. Journal of Molecular Graphics 1996 14 1 33 38 2-s2.0-0029878720 10.1016/0263-7855(96)00018-5
42. Elkayam E., Kuhn C.-D., Tocilj A., The structure of human argonaute-2 in complex with miR-20a. Cell 2012 150 100 110
43. Brown S. C., Thomson S. A., Veal J. M., Davis D. G., NMR solution structure of a peptide nucleic acid complexed with RNA. Science 1994 265 5173 777 780 2-s2.0-0028066788
44. Hornak V., Abel R., Okur A., Strockbine B., Roitberg A., Simmerling C., Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function and Genetics 2006 65 3 712 725 2-s2.0-33748518255 10.1002/prot.21123
45. Case D.A., Darden T.A., Cheatham T.E. III, AMBER 12. University of California, 2012
46. Sanders J. M., Wampole M. E., Chen C.-P., Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: theory and experiment. The Journal of Physical Chemistry B 2013 10.1021/jp4064966
47. Dupradeau F.-Y., Cézard C., Lelong R., Stanislawiak É., Pê;cher J., Delepine J. C., Cieplak P., R.E.DD.B.: a database for RESP and ESP atomic charges, and force field libraries. Nucleic Acids Research 2008 36 1 D360 D367 2-s2.0-38549152775 10.1093/nar/gkm887
48. Craft J. W. Jr., Legge G. B., An AMBER/DYANA/MOLMOL phosphorylated amino acid library set and incorporation into NMR structure calculations. Journal of Biomolecular NMR 2005 33 1 15 24 2-s2.0-27644545507 10.1007/s10858-005-1199-0
49. Soliva R., Sherer E., Luque F. J., Laughton C. A., Orozco M., Molecular dynamics simulations of PNA·DNA and PNA·RNA duplexes in aqueous solution. Journal of the American Chemical Society 2000 122 25 5997 6008 2-s2.0-0034725383 10.1021/ja000259h
50. Panecka J., Mura C., Trylska J., Molecular dynamics of potential rRNA binders: single-stranded nucleic acids and some analogues. Journal of Physical Chemistry B 2011 115 3 532 546 2-s2.0-78751662136 10.1021/jp106404u